Temasek
VC Fund
Singapore, Singapore
Temasek is a VC fund in Singapore focused on Biotechnology and Health Care. Temasek deploys financial capital into businesses to generate sustainable, long-term financial returns. Its investment activities span key sectors such as financial services, technology, life sciences, consumer goods, and energy infrastructure. Beyond direct funding, the institution engages with its portfolio enterprises to foster corporate governance and long-term value creation. Through an international network of operating offices, the entity monitors global market trends to identify sustainable development opportunities and capital deployment pathways.
- Total investments:
- 670
- Last investment:
- Lead investor:
- 46%
- Fund size:
- $283M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Temasek invests in
Stages Temasek invests in
Countries Temasek invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 25 contacts → | |||
Round size
- Series B
- $29M–$250M
- Series C
- $28M–$400M
- Series D
- $43M–$460M
Investment Focus
Industry
- Biotechnology 73 (11%)
- Health Care 65 (10%)
- Software 58 (9%)
- Artificial Intelligence 46 (7%)
- E-Commerce 43 (6%)
Stage
- Series B 105 (16%)
- Series C 102 (15%)
- Series D 73 (11%)
- Private Equity 69 (10%)
- Series A 53 (8%)
Country
- United States 162 (24%)
- China 83 (12%)
- India 44 (7%)
- Singapore 27 (4%)
- United Kingdom 26 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Beng Teck Ong
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Benoit Valentin
Senior Managing Director EMEA, and Head of Private Equity Fund Investments
|
Senior Managing Director EMEA, and Head of Private Equity Fund Investments | Total investments: 2 | Find email | |
|
David Heng
Joint Head, Consumer; Head, Real Estate; Joint Head, China; Head, Japan & Korea
|
Joint Head, Consumer; Head, Real Estate; Joint Head, China; Head, Japan & Korea | Total investments: 3 | Find email | |
Eric Bielke
Director
|
Director | Total investments: 1 | Find email | |
John Marren
Senior Managing Director
|
Senior Managing Director | Total investments: 1 | Find email | |
| See all 25 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Soufflé Therapeutics is a biotechnology company specializing in the development of nucleic acid medicines designed for precise delivery and targeting of disease-causing cells. The company's mission is to create potent, precise, and safe medicines that can be tailored for a broad range of diseases by leveraging breakthroughs in genetic medicineand drug delivery technology. | $135M / Series B / Oct 13, 2026 | ||
| Vinci4D.AI utilizes generative artificial intelligence to create hardware design. Its services cover the design, development, and deployment of software. It facilitates users to process and encode three-dimensional geometry with the necessary level of resolution for design and manufacturing. | $250M / Series B / Oct 06, 2026 | ||
| Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes. | $555M / Series G / Oct 01, 2026 | ||
| Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes. | $622M / Secondary Market / Oct 01, 2026 | ||
| FSI professionals have been working as a team since 2012. At the five years of engagement in Fondo Strategico Italiano, the team has developed a solid track record and improved team spirit, laying the foundations for FSI's activities. | Private Equity / Sep 28, 2026 | ||
| Romsons International is a leading manufacturer of disposable medical devices company. | Private Equity / Sep 22, 2026 | ||
| The Boring Company is an infrastructure and tunnel construction company that facilitates underground transportation networks. It aims to create safe, fast-to-dig, and low-cost transportation, utility, and freight tunnels. | $3B / Series D / Sep 09, 2026 | ||
| Adani Airports, a subsidiary of the Adani Group, is a private airport operator that provides a wide range of services and modern infrastructure. It manages and operates eight major airports across the country. These include Mumbai, Ahmedabad, Lucknow, Mangaluru, Jaipur, Guwahati, Thiruvananthapuram, and the upcoming Navi Mumbai InternationalAirport. The company is focused on transforming these airports into world-class travel hubs by providing a wide range of services and modern infrastructure.Passenger services include the Pranaam Meet & Greet service, porter assistance, access to premium lounges, duty-free shopping, diverse food and beverage options, and complimentary Wi-Fi. The airports also offer essential amenities such as on-site medical facilities, baby care rooms, prayer rooms, and special assistance for passengers with reduced mobility. Many of these services can be booked through the Adani One platform. | $1B / Private Equity / Sep 09, 2026 | ||
| Databricks is a software platform that helps its customers unify their analytics across the business, data science, and data engineering. It also provides a Unified Analytics Platform for data science teams to collaborate with data engineering and lines of business to build data products. The company was founded in 2013 and is headquartered inSan Francisco, California. | $5B / Private Equity / Aug 13, 2026 | ||
| River AI develops personal AI technologies and provides an API for training and adapting open-source AI models. Its API supports LoRA-based fine-tuning and reinforcement learning, allowing users to train, sample, and serve customized models using their own data and rewards. The company also develops personalization, continual learning, AIinfrastructure, and personal hardware for AI systems designed to operate under individual user control. | $1.1B / Series A / Aug 11, 2026 | ||
| See all 670 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Temasek invest in?
Temasek invests primarily in Biotechnology, Health Care and Software startups, most often at Series B and Series C stage. Most of the 670 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Temasek invest in?
Temasek typically joins rounds of $29M–$250M at Series B, $28M–$400M at Series C and $43M–$460M at Series D. These are whole funding-round sizes, not Temasek's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Temasek took part in.
How do I contact Temasek?
Public channels for Temasek include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Temasek?
The team at Temasek includes Beng Teck Ong (Managing Director), Benoit Valentin (Senior Managing Director EMEA, and Head of Private Equity Fund Investments) and David Heng (Joint Head, Consumer; Head, Real Estate; Joint Head, China; Head, Japan & Korea), among 25 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
